MsGizmo said:
Airborne Daddy said:
When it comes to BPC 157, the general consensus is that it works best if you inject it right near where you're hurt. I tore a bicep tendon myself, but I was too chicken to shoot it into the surgically fixed tendon, so I rotated injections between my bicep and forearm for 6 weeks. Ended up returning to work without needing any physical therapy. TB500 could be useful, but it doesn't have the ability to target a specific area. As for the other compounds in glow/klow, I'm clueless—I always assumed those were for appearance, like skin, collagen, and elasticity. If it were me, I'd inject the TB and BPC as separate shots over a 6 to 8 week period.
Who exactly is saying that? And based on what proof? That's the same logic as claiming you should shoot your GLP1 into whichever areas you want to shrink the most. That isn't how any of this works.
What likely started this belief is that painkillers get injected close to the spot that hurts, since they're basically a numbing substance and they do work right where they land. Take novocaine — it will affect whatever tissue it contacts, but it performs best when it directly touches the nerves. BPC works differently: it has to enter the bloodstream first, so the injection location makes no difference. That applies to the majority of medications.
Nothing at all supports the idea that picking more painful spots to inject gives you better outcomes.